Neuigkeiten

MakroCare - Drug Development and Commercialization Partner

Cover Image

Neuigkeiten

MakroCare - Drug Development and Commercialization Partner 
MakroCare - Drug Development and Commercialization Partner
MakroCare - Drug Development and Commercialization Partnerhat einen Beitrag geschrieben.7. Mai 2015
Randomized controlled trial (RCT) is the gold standard for evaluating a new drug in comparison with a standard drug or placebo. However, RCT has a few limitations such as a particular treatment regimen will be given to a patient based on his willingness for randomization, he may not be a representative sample of the clinical population due to stringent inclusion / exclusion criteria, his treatment management may be slightly different from routine clinical practice etc.   These limitations m...
MakroCare - Drug Development and Commercialization Partner
MakroCare - Drug Development and Commercialization Partnerhat einen Beitrag geschrieben.13. April 2015
  http://goo.gl/TRSGOp iDOT is a strategic approach towards delivering standardized services and technology in an integrated manner. Defining the right parameters / scope of the service and developing the right combination of ‘end to end process, teams and tools’ are the key activities that drive best value to customers.